Drug Eluting Stent Market to Grow at 3.45% CAGR to 2020

Mar 09, 2016, 05:00 ET from RnR Market Research

PUNE, India, March 9, 2016 /PRNewswire/ --

High incidence of atherosclerosis diseases will drive drug-eluting stent market growth, globally, as angina, heart attack, stroke, and transient ischemic attack rise and presence of many vendors offering drug eluting stents. To survive in the competitive environment, maintaining the market share is important that will lead to an increase in mergers and acquisitions, sales agreements, and distribution agreements.

Complete report on drug - eluting stent market of 56 pages, providing 28 exhibits and analysing 5 major companies is at available at http://www.rnrmarketresearch.com/global-drug-eluting-stent-market-2016-2020-market-report.html.

The analysts forecast global drug - eluting stent market to grow at a CAGR of 3.45% during the period 2016-2020. According to the Global Drug - Eluting Stent Market 2016 - 2020 report, an increase in the incidence of atherosclerosis diseases such as angina, heart attack, stroke, and transient ischemic attack is the primary driver for the growth of the global drug - eluting stent market. A drug - eluting stent is used in the treatment of atherosclerosis diseases. Rise in obesity, excessive smoking, diabetes, alcohol consumption, and unhealthy lifestyle are the major factors that contribute to the increased incidence of atherosclerosis diseases.

In 2015, the Americas was the largest market for drug - eluting stent products as it accounted for close to 41% of the market share. However, the US market is slowly getting saturated and is expected to lose its market share in terms of revenue because of increasing competition and declining prices of drug - eluting stent products.

The global market for the drug - eluting stent is highly fragmented due to the presence of several well-established vendors. The competition is expected to intensify with an increase in product portfolio extensions with next-generation products, technological innovations, and mergers and acquisitions. Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=494958.

The following companies are the key players in the Global Drug - Eluting Stent Market: Abbott Laboratories, Biosensors International Group, Boston Scientific, Medtronic, and Terumo Corporation. Other Prominent Vendors in the market are: Biotronik, Cook Medical, Envision Scientific, Lepu Medical, Meril Life Sciences, MicroPort Medical, Opto Circuits, Shandong JW Medical Systems and STENTYS.

Further, the report states that the declining average selling price of drug - eluting stents is however impeding market growth. The competition in the market has increased with the growing presence of many local vendors. This factor pushes vendors to adopt a competitive pricing strategy that results in the decline in the price of products, affecting the profit margins of global vendors.

Another related report is Global Stent Grafts Market 2015 - 2019 and says this market is expected to post a steady market growth rate of more than 6% by 2019 owing to the growing incidence of aortic aneurysm among the aging population. The market research analyst has estimated the abdominal aortic aneurysm (AAA) stent grafts segment to account for more than 82% of the total market share by 2019. These stent grafts are useful in treating AAA and function by attaching itself to the aorta wall in a spring like fashion.

In this market research report, analysts estimate the Americas to dominate the global market for stent grafts followed by the EMEA and the APAC regions. High incidence of aortic aneurysm in the US is responsible for this region's high market dominion during the forecast period. Browse report at http://www.rnrmarketresearch.com/global-stent-grafts-market-2015-2019-market-report.html.

Competitive landscape and key vendors: This market is well organized and is highly competitive due to the presence of multiple vendors. The dominant vendors account for a major share of the market during the forecast period and face occasional competition from local manufacturers in various countries.

Key vendors in this market are Cook Medical, C.R Bard and Medtronic. Other prominent vendors in this market include Aptus Endosystem, Bolton Medical, Cordis, GRIKIN Advanced Materials, LifeTech Scientific, Lombard Medical, St. George Medical, Terumo (Vascutek), TriVascular, WL Gore & Associates, Bolton Medical, Endologix, Johnson & Johnson, Jotec, Lombard Medical Technologies, Terumo, and TriVascular Technologies.

Explore other reports on medical devices market at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices.

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

SOURCE RnR Market Research